4//SEC Filing
Loschinskey Dave 4
Accession 0001104659-20-013514
CIK 0001610092other
Filed
Feb 9, 7:00 PM ET
Accepted
Feb 10, 4:17 PM ET
Size
18.8 KB
Accession
0001104659-20-013514
Insider Transaction Report
Form 4
Loschinskey Dave
Chief Operating Officer
Transactions
- Disposition from Tender
Common Stock
2020-02-10$4.00/sh−994$3,976→ 0 total(indirect: By Spouse) - Disposition to Issuer
Common Stock
2020-02-10−27,750→ 1,778 total - Disposition to Issuer
Common Stock
2020-02-10−200,000→ 29,528 total - Disposition to Issuer
Employee Stock Option to Acquire Common Stock
2020-02-10−100,000→ 0 totalExercise: $1465.58Exp: 2027-11-06→ Common Stock (100,000 underlying) - Disposition to Issuer
Common Stock
2020-02-10−1,778→ 0 total - Disposition to Issuer
Employee Stock Option to Acquire Common Stock
2020-02-10−9,508→ 0 totalExercise: $1441.00Exp: 2028-03-27→ Common Stock (9,508 underlying) - Disposition from Tender
Common Stock
2020-02-10$4.00/sh−99,044$396,176→ 229,528 total - Disposition to Issuer
Employee Stock Option to Acquire Common Stock
2020-02-10−76,132→ 0 totalExercise: $417.14Exp: 2029-05-10→ Common Stock (76,132 underlying)
Footnotes (6)
- [F1]Represents shares tendered to the Denali Merger Sub, Inc. ("Purchaser") in connection with the closing on February 10, 2020 of a cash tender offer by Purchaser to acquire common stock of Issuer in exchange for $4.00 per share in cash, subject to any required withholding of taxes, without interest.
- [F2]Shares held directly by the Reporting Person's spouse.
- [F3]Pursuant to an Agreement and Plan of Merger, dated December 9, 2019 (the "Merger Agreement"), by and among UnitedHealth Group Incorporated, a Delaware corporation ("Parent"), Purchaser, a Michigan corporation and a wholly owned subsidiary of Parent and Diplomat Pharmacy, Inc., a Michigan corporation (the "Issuer"), certain outstanding restricted stock unit awards held by reporting person were converted into equity awards of the Parent pursuant to the closing on February 10, 2020 of the merger of Purchaser with and into the Issuer. These shares remain subject to time-based vesting requirements.
- [F4]One-fourth of the options vest on each of the first, second, third and anniversary of the grant date (November 6, 2017).
- [F5]One-third of the options vest on each of the first, second and third anniversary of the grant date (March 27, 2018).
- [F6]One-third of the options vest on each of the first, second and third anniversary of the grant date (May 10, 2019).
Documents
Issuer
Diplomat Pharmacy, Inc.
CIK 0001610092
Entity typeother
Related Parties
1- filerCIK 0001775209
Filing Metadata
- Form type
- 4
- Filed
- Feb 9, 7:00 PM ET
- Accepted
- Feb 10, 4:17 PM ET
- Size
- 18.8 KB